New HealthMyne QIDS 3.0 Platform Addresses Incidental Findings Workflow

Timely follow up means earlier treatment, better outcomes, and substantial cost savings

MADISON, WI, USA, October 12, 2017 /EINPresswire.com/ -- Incidental lesions are discovered in up to 30% of imaging studies, yet follow up is generally poor. It is well known that the earlier cancer is detected, the higher the probability of long-term survival. Additionally, costs for cancer treatment increase dramatically when started in later stages of the disease. In their continued effort to provide improved patient care solutions to radiologists and multidisciplinary teams, HealthMyne announced today the release of QIDS 3.0. This version includes the Incidental Findings Workflow module along with many other new features and enhancements.

The new module allows radiologists to tag a finding as incidental directly in their workflow. A web-based worklist of all patients with incidental findings is then created by the software. Follow up can be automatically scheduled based on protocols such as Fleischner Society Guidelines or a care coordinator can set custom dates. Patient calls can be logged directly in the worklist and letters can also be generated right from the web-based queue. Notifications are sent to appropriate clinicians when a follow up has not taken place in the indicated timeframe. Patient information is also highlighted in red in the worklist to ensure all patients receive proper care.

“This new module can significantly help organizations provide the appropriate follow-up to patients with incidental findings.” asserts Dr. Linda Peitzman, CMIO for HealthMyne, “In many healthcare systems, follow-up of these lesions is manual and inefficient, and unfortunately patients often fall through the cracks. Some of these patient’s findings progress to cancer, and earlier follow-up can save lives. HealthMyne's new Incidental Findings functionality automates tracking and aids the organization in closing the loop for this difficult problem, so we can provide the best possible care to our patients.”

Other features and enhancements included in QIDS 3.0 are: improvements in therapy response protocol management and reporting, integration with MModal® Structured Elements, and enhancements to the Rapid Precise Metrics (RPM)™ functionality for faster confirmation and easier analysis of lesion metrics.

For additional information visit www.healthmyne.com

About HealthMyne

HealthMyne, Inc. (Madison, WI) is focused on delivering Quantitative Imaging Decision Support (QIDS)™ for Radiology and Oncology with expansion to other clinical specialties and non-US markets over time. The company’s FDA-cleared software platform delivers image quantification, analytics, and other clinical systems data (e.g. PACS, EMR, RT) into multiple workflows to ensure timely clinical decision support at the point of care. The QIDS platform provides curated metrics, content, alerts, analytics, and reporting to optimize clinical collaboration among the multi-disciplinary care team and enable precise patient management and patient-centric care. The QIDS platform’s discoverable database supports data mining and AI-based application development for Precision Medicine/Big Data initiatives and for general clinical, translational, and commercial research.

Neal Miller
HealthMyne
6088332610
email us here